Search

Louise Wang Zhiying Humphrey

Supervisory Patent Examiner (ID: 6195, Phone: (571)272-5543 , Office: P/1657 )

Most Active Art Unit
1648
Art Unit(s)
1648, 1657
Total Applications
627
Issued Applications
269
Pending Applications
52
Abandoned Applications
312

Applications

Application numberTitle of the applicationFiling DateStatus
10/019368 Antisense oligonucleotide modulation of human protein kinase c-delta expression Jun 1, 2005 Abandoned
Array ( [id] => 5895418 [patent_doc_number] => 20060003957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'RNA virus expression and replication, methods and uses therefor' [patent_app_type] => utility [patent_app_number] => 11/122944 [patent_app_country] => US [patent_app_date] => 2005-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 27385 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20060003957.pdf [firstpage_image] =>[orig_patent_app_number] => 11122944 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/122944
RNA virus expression and replication, methods and uses therefor May 4, 2005 Abandoned
Array ( [id] => 5591429 [patent_doc_number] => 20060040881 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => 'Modulators of coagulation factors' [patent_app_type] => utility [patent_app_number] => 11/113378 [patent_app_country] => US [patent_app_date] => 2005-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 23172 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040881.pdf [firstpage_image] =>[orig_patent_app_number] => 11113378 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/113378
Modulators of coagulation factors Apr 21, 2005 Issued
Array ( [id] => 7216482 [patent_doc_number] => 20050260166 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-24 [patent_title] => 'Expressional enhancers from viruses' [patent_app_type] => utility [patent_app_number] => 11/107315 [patent_app_country] => US [patent_app_date] => 2005-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11177 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0260/20050260166.pdf [firstpage_image] =>[orig_patent_app_number] => 11107315 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/107315
Expressional enhancers from viruses Apr 14, 2005 Abandoned
Array ( [id] => 5062561 [patent_doc_number] => 20070224200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'Gm3 Synthase as a Therapeutic Target in Microvascular Complications of Diabetes' [patent_app_type] => utility [patent_app_number] => 11/579725 [patent_app_country] => US [patent_app_date] => 2005-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10212 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20070224200.pdf [firstpage_image] =>[orig_patent_app_number] => 11579725 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/579725
Gm3 Synthase as a Therapeutic Target in Microvascular Complications of Diabetes Apr 6, 2005 Abandoned
Array ( [id] => 5156189 [patent_doc_number] => 20070039072 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-15 [patent_title] => 'Functional and hyperfunctional siRNA' [patent_app_type] => utility [patent_app_number] => 11/093832 [patent_app_country] => US [patent_app_date] => 2005-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 49885 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0039/20070039072.pdf [firstpage_image] =>[orig_patent_app_number] => 11093832 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/093832
Functional and hyperfunctional siRNA Mar 28, 2005 Abandoned
Array ( [id] => 795554 [patent_doc_number] => 07429468 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-30 [patent_title] => 'Mutant B-type DNA polymerases exhibiting improved performance in PCR' [patent_app_type] => utility [patent_app_number] => 11/077886 [patent_app_country] => US [patent_app_date] => 2005-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6222 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/429/07429468.pdf [firstpage_image] =>[orig_patent_app_number] => 11077886 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/077886
Mutant B-type DNA polymerases exhibiting improved performance in PCR Mar 10, 2005 Issued
Array ( [id] => 4651093 [patent_doc_number] => 20080038349 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-14 [patent_title] => 'Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase' [patent_app_type] => utility [patent_app_number] => 10/589755 [patent_app_country] => US [patent_app_date] => 2005-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9915 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20080038349.pdf [firstpage_image] =>[orig_patent_app_number] => 10589755 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/589755
Peptide-Pna Chimera Targeting Inducible Nitric Oxide Synthetase Feb 9, 2005 Abandoned
Array ( [id] => 10115734 [patent_doc_number] => 09150606 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-10-06 [patent_title] => 'Compositions comprising alternating 2\'-modified nucleosides for use in gene modulation' [patent_app_type] => utility [patent_app_number] => 11/054848 [patent_app_country] => US [patent_app_date] => 2005-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36064 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11054848 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/054848
Compositions comprising alternating 2'-modified nucleosides for use in gene modulation Feb 8, 2005 Issued
Array ( [id] => 7200182 [patent_doc_number] => 20050164974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Nucleic acid ligand complexes' [patent_app_type] => utility [patent_app_number] => 11/050017 [patent_app_country] => US [patent_app_date] => 2005-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 34 [patent_no_of_words] => 23121 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164974.pdf [firstpage_image] =>[orig_patent_app_number] => 11050017 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/050017
Nucleic acid ligand complexes Feb 2, 2005 Abandoned
Array ( [id] => 6912291 [patent_doc_number] => 20050176049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Detecting surface to detect interaction between substances, sensor chip and sensing device equipped with detecting surface, and detecting method' [patent_app_type] => utility [patent_app_number] => 11/050560 [patent_app_country] => US [patent_app_date] => 2005-02-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6415 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20050176049.pdf [firstpage_image] =>[orig_patent_app_number] => 11050560 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/050560
Detecting surface to detect interaction between substances, sensor chip and sensing device equipped with detecting surface, and detecting method Feb 1, 2005 Abandoned
Array ( [id] => 6945260 [patent_doc_number] => 20050197309 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-08 [patent_title] => 'Antisense modulation of dual specific phosphatase 5 expression' [patent_app_type] => utility [patent_app_number] => 11/035809 [patent_app_country] => US [patent_app_date] => 2005-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25244 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0197/20050197309.pdf [firstpage_image] =>[orig_patent_app_number] => 11035809 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/035809
Antisense modulation of dual specific phosphatase 5 expression Jan 13, 2005 Abandoned
Array ( [id] => 7043023 [patent_doc_number] => 20050160490 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-21 [patent_title] => 'Methods and means for producing efficient silencing construct using recombinational cloning' [patent_app_type] => utility [patent_app_number] => 11/033553 [patent_app_country] => US [patent_app_date] => 2005-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 13175 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20050160490.pdf [firstpage_image] =>[orig_patent_app_number] => 11033553 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/033553
Methods and means for producing efficient silencing construct using recombinational cloning Jan 11, 2005 Issued
Array ( [id] => 263771 [patent_doc_number] => 07569536 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-04 [patent_title] => 'Method for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity' [patent_app_type] => utility [patent_app_number] => 10/584482 [patent_app_country] => US [patent_app_date] => 2004-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 31717 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/569/07569536.pdf [firstpage_image] =>[orig_patent_app_number] => 10584482 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/584482
Method for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activity Dec 23, 2004 Issued
Array ( [id] => 211547 [patent_doc_number] => 07622453 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-24 [patent_title] => 'Oligomeric compounds for the modulation of Bcl-2' [patent_app_type] => utility [patent_app_number] => 11/021729 [patent_app_country] => US [patent_app_date] => 2004-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 25 [patent_no_of_words] => 26627 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/622/07622453.pdf [firstpage_image] =>[orig_patent_app_number] => 11021729 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/021729
Oligomeric compounds for the modulation of Bcl-2 Dec 22, 2004 Issued
Array ( [id] => 270648 [patent_doc_number] => 07563884 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-07-21 [patent_title] => 'Antisense modulation of PTP1B expression' [patent_app_type] => utility [patent_app_number] => 11/008747 [patent_app_country] => US [patent_app_date] => 2004-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28842 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/563/07563884.pdf [firstpage_image] =>[orig_patent_app_number] => 11008747 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/008747
Antisense modulation of PTP1B expression Dec 8, 2004 Issued
Array ( [id] => 6918731 [patent_doc_number] => 20050096292 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Notch1 inhibitors for inducing apoptosis' [patent_app_type] => utility [patent_app_number] => 10/991147 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31413 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096292.pdf [firstpage_image] =>[orig_patent_app_number] => 10991147 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/991147
Notch1 inhibitors for inducing apoptosis Nov 16, 2004 Abandoned
Array ( [id] => 7098468 [patent_doc_number] => 20050130927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Antisense oligonucleotide preparation method' [patent_app_type] => utility [patent_app_number] => 10/984919 [patent_app_country] => US [patent_app_date] => 2004-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 6969 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130927.pdf [firstpage_image] =>[orig_patent_app_number] => 10984919 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/984919
Antisense oligonucleotide preparation method Nov 9, 2004 Issued
Array ( [id] => 5774676 [patent_doc_number] => 20050268351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-01 [patent_title] => 'Modulation of storage organs' [patent_app_type] => utility [patent_app_number] => 10/981029 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8111 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0268/20050268351.pdf [firstpage_image] =>[orig_patent_app_number] => 10981029 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/981029
Modulation of storage organs Nov 2, 2004 Abandoned
Array ( [id] => 5085868 [patent_doc_number] => 20070275919 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Rna Amidates and Thioamidates for Rnai' [patent_app_type] => utility [patent_app_number] => 10/578530 [patent_app_country] => US [patent_app_date] => 2004-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 12707 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20070275919.pdf [firstpage_image] =>[orig_patent_app_number] => 10578530 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/578530
RNA amidates and thioamidates for RNAi Nov 2, 2004 Issued
Menu